Next Generation of Cervical Cancer Treatments
Recent options for cervical cancer treatment focus on discovering new medications and immunotherapy. One notable progress is the use of pembrolizumab in advanced stages and the use of combined chemotherapy with checkpoint inhibitors. Also, clinical trials are starting to use antibody-drug conjugates such as nivolumab vedotin. Such inventions or improvements are aimed at cancer treatment and give prospects for patients already with advanced or recurrent cervical cancer who have despaired of surgical or radiation relief methods.
